We’re proud to announce that on June 26, 2024, Xaga Surgical was granted an EU
patent for the Forsvall Biopsy Instrument. This important milestone protects our
innovative needle design aimed at significantly reducing infection risk and enhancing
diagnostic precision in prostate biopsies. The EU patent strengthens our intellectual
property portfolio and supports our mission to deliver safer, more effective biopsy
solutions for patients across Europe and beyond.
Xaga receives EU patent for the Forsvall Biopsy Instrument
